Stockscreener 앱 받기
9.18
0.88%
+0.08
시간 외 거래:
9.18
전일 마감가:
$9.10
열려 있는:
$9.08
하루 거래량:
365.64K
시가총액:
$537.25M
수익:
-
순이익/손실:
$-201.59M
주가수익비율:
-2.0959
EPS:
-4.38
순현금흐름:
$-139.21M
1주 성능:
+2.34%
1개월 성능:
-12.57%
6개월 성능:
+7.75%
1년 성능:
-10.09%
1일 변동 폭
$8.96
$9.43
52주 변동 폭
$6.065
$17.02
Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile
명칭
Phathom Pharmaceuticals Inc
전화
877 742 8466
주소
100 Campus Drive, Suite 102, Florham Park, NJ
Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-09 | 개시 | H.C. Wainwright | Buy |
| 2023-05-11 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2023-03-13 | 개시 | Craig Hallum | Buy |
| 2022-10-21 | 개시 | Jefferies | Buy |
| 2022-05-06 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-05-12 | 업그레이드 | Goldman | Sell → Neutral |
| 2021-02-17 | 개시 | BMO Capital Markets | Outperform |
| 2021-02-02 | 개시 | Guggenheim | Buy |
| 2020-06-26 | 다운그레이드 | Goldman | Neutral → Sell |
| 2019-11-20 | 개시 | Evercore ISI | Outperform |
| 2019-11-19 | 개시 | Goldman | Neutral |
| 2019-11-19 | 개시 | Jefferies | Buy |
| 2019-11-19 | 개시 | Needham | Buy |
모두보기
Phathom Pharmaceuticals Inc 주식(PHAT)의 최신 뉴스
Phathom Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference
GlobeNewswire Inc.
Phathom Pharmaceuticals Launches Direct-to-Consumer Campaign, “VOQUEZNA Can Kick Some Acid”
GlobeNewswire Inc.
Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire Inc.
Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on Thursday, March 7, 2024
GlobeNewswire Inc.
Walmart Posts Upbeat Earnings, Joins Armstrong World Industries, Owens & Minor And Other Big Stocks Moving Higher On Tuesday
Benzinga
Phathom Pharmaceuticals to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
GlobeNewswire Inc.
Phathom Pharmaceuticals Inc (PHAT) 재무 분석
Phathom Pharmaceuticals Inc (PHAT) 순이익 2024
PHAT은 2023-12-31 종료 분기에 대해 순이익(지난 12개월)이 -201.59M 달러로 보고했으며, 전년대비 -1.96% 감소했습니다.
Phathom Pharmaceuticals Inc (PHAT) 현금흐름 2024
2023-12-31 종료 분기에 PHAT은 현금흐름(지난 12개월)으로 -139.21M 달러를 기록했으며, 전년 대비 +5.66% 증가했습니다.
Phathom Pharmaceuticals Inc (PHAT) 주당 순이익 2024
PHAT이 보고한 2023-12-31 종료 분기의 주당 순이익(지난 12개월)은 -3.94달러이며, 전년 대비 +21.98% 성장했습니다.
Phathom Pharmaceuticals Inc 주식 (PHAT) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Curran Terrie | President and Chief Executive |
Mar 22 '24 |
Sale |
9.11 |
16,851 |
153,513 |
410,784 |
| TAKEDA PHARMACEUTICAL CO LTD | 10% Owner |
Jan 24 '24 |
Sale |
8.10 |
3,703,703 |
29,999,994 |
3,755,583 |
| Henderson Molly | CFO and CBO |
Jan 19 '24 |
Sale |
7.75 |
6,307 |
48,900 |
98,698 |
| Henderson Molly | CFO and CBO |
Nov 20 '23 |
Sale |
7.24 |
2,127 |
15,403 |
103,061 |
| Parikh Asit | Director |
Nov 08 '23 |
Buy |
7.80 |
2,500 |
19,500 |
55,000 |
| Parikh Asit | Director |
Nov 07 '23 |
Buy |
7.76 |
4,000 |
31,040 |
52,500 |
| Parikh Asit | Director |
Nov 06 '23 |
Buy |
8.04 |
1,000 |
8,040 |
48,500 |
| Henderson Molly | CFO and CBO |
Nov 01 '23 |
Sale |
8.88 |
12,492 |
110,871 |
105,188 |
| Henderson Molly | CFO and CBO |
Jun 02 '23 |
Sale |
11.41 |
1,960 |
22,368 |
68,506 |
| Henderson Molly | CFO and CBO |
May 22 '23 |
Sale |
12.87 |
2,110 |
27,165 |
70,466 |
1.53%
3.38%
자본화:
|
볼륨(24시간):